This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-CCR7 monoclonal antibody, clone 4E23 [APC]
catalog :
DCABH-4530
quantity :
50 Tests
clonality :
monoclonal
host :
mouse
conjugate :
APC
clone name :
4E23
reactivity :
human
application :
flow cytometry
product information
Cat :
DCABH-4530
Product Name :
Anti-CCR7 monoclonal antibody, clone 4E23 [APC]
Brand :
Creative Diagnostics
Abbr :
Anti-CCR7 MAb, APC-Conjugated
Host animal :
Mouse
Clone :
4E23
Official Symbol :
CCR7
Clonality :
Monoclonal
Application :
FC
Target :
CCR7
Species Reactivity :
Human
Conjugate :
APC
Antibody Type :
Primary Antibodies
Immunogen :
The details of the immunogen for this antibody are not available.
Alternative Names :
CCR7; chemokine (C-C motif) receptor 7; CMKBR7, EBI1; C-C chemokine receptor type 7; BLR2; CD197; CDw197; CCR-7; CC-CKR-7; C-C CKR-7; MIP-3 beta receptor; CC chemokine receptor 7; chemokine (C-C) receptor 7; Epstein-Barr virus induced gene 1; EBV-induced
UniProt ID :
P32248
Antibody Isotype :
IgG2a
Size :
50 Tests
Storage :
Store at +4°C.
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments